Study how a beta-3 drug changes body fat in healthy adults
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This Phase 1 study tests how chronic treatment with a beta-3–type medicine affects brown fat (a special kind of body fat) in the body. It mainly looks at safety and how the body responds over time, which could help future treatments for weight and metabolic health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and agree to sign a consent form
- You are age 18 to 40 and your BMI is 18 to 40 (or meet the PCOS criteria below)
- You must fit one of the study groups: female or male (general group), or a PCOS group with specific hormone/ovulation and insulin-resistance signs
- If you can become pregnant, you must use very reliable birth control starting at least 3 months before and during the study
- You must not have certain health problems (especially diabetes, uncontrolled blood pressure, heart rhythm issues, or thyroid problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how body fat and exercise relate to how your ovaries work and how your hormones function. It may help explain why some women have irregular ovulation or hormone problems, and how lifestyle factors affect them.
This study looks at hormone levels and metabolism in people who may have polycystic ovary syndrome (PCOS). It aims to better understand why PCOS happens, which could help improve future diagnosis and treatment.
This trial looks at a specific type of PCOS (polycystic ovary syndrome) that has high levels of amino acids called BCAAs. It aims to understand this condition better and see how it affects first-time IVF treatment, which may help personalize your care.
This study looks at how weight changes affect hormone levels and insulin resistance in women with PCOS. It may help understand if weight cycling is harmful or helpful.
This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.
This Phase 2 study tests whether a combination medicine—alpha-lipoic acid plus mirabegron—can help people manage obesity. It will study safety and whether the treatment can improve weight-related outcomes in adults.
Hear when a new Polycystic Ovary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.